Endometriosis
Showing NaN - NaN of 13
Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix
Active, not recruiting
- Endometriosis
- 75 mg linzagolix tablet
- +5 more
-
Dothan, Alabama
- +46 more
Jan 12, 2023
Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)
Active, not recruiting
- Endometriosis
- Relugolix
- Estradiol/norethindrone acetate
-
Andalusia, Alabama
- +168 more
May 31, 2022
Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)
Active, not recruiting
- Endometriosis
- Estradiol/Norethindrone Acetate
- +3 more
-
Birmingham, Alabama
- +196 more
Feb 14, 2022
Women Receiving Standard of Care for Treatment of Pelvic Pain
Terminated
- Endometriosis
- +2 more
-
Birmingham, Alabama
- +116 more
Nov 16, 2021
Bone Mineral Density in Uterine Fibroids or Endometriosis
Completed
- Uterine Fibroid
- Endometriosis
-
Mobile, Alabama
- +62 more
Nov 6, 2020
Intestinal Permeability and Endometriosis
Completed
- Endometriosis
- lactulose:mannitol (L:M) oral challenge
-
Chattanooga, Tennessee
- +1 more
Apr 27, 2020